Page last updated: 2024-12-05

myristic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Myristic acid, also known as tetradecanoic acid, is a saturated fatty acid with the formula CH3(CH2)12COOH. It is found naturally in many plants and animals, including palm kernel oil, coconut oil, nutmeg, and milk. Myristic acid is a white, waxy solid at room temperature and is relatively insoluble in water. It is a common component of many fats and oils, and it is used in a variety of industrial and commercial applications. Myristic acid is also found in the body, where it plays a role in various biological processes, including cell signaling and immune function. It is known to be a potent anti-inflammatory agent and has been shown to reduce the risk of heart disease and cancer in some studies. Because of its various biological activities, myristic acid is the subject of ongoing research to explore its potential therapeutic applications.'

Myristic Acid: A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tetradecanoic acid : A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

tetradecanoate : A long-chain fatty acid anion that is the conjugate base of myristic acid; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11005
CHEMBL ID111077
CHEBI ID28875
SCHEMBL ID6374
MeSH IDM0029411

Synonyms (145)

Synonym
32112-52-0
nsc 122834
einecs 250-924-5
smr001224536
MLS002152942
bdbm50147581
acid, tetradecanoic
acid, myristic
crodacid
nsc5028 ,
nsc-5028
univol u 316s
hydrofol acid 1495
wln: qv13
n-tetradecanoic acid
n-tetradecoic acid
1-tridecanecarboxylic acid
emery 655
myristinsaeure
tetradecoic acid
acide tetradecanoique
CHEBI:28875 ,
1-tetradecanecarboxylic acid
ch3-[ch2]12-cooh
n-tetradecan-1-oic acid
myristate
n-tetradecan-1-oate
hystrene 9014
philacid 1400
tetradecanoic acid (9ci)
ai3-15381
fema no. 2764
prifac 2942
hsdb 5686
edenor c 14
ccris 4724
myristic acid (natural)
myristic acid, pure
myristic acid (8ci)
NCGC00091068-01
nsc 5028
brn 0508624
einecs 208-875-2
544-63-8
tetradecanoic acid
C06424
tetradecanoate
myristic acid
myristic acid, sigma grade, >=99%
myristic acid, >=95%, fcc, fg
myristic acid, natural
c14:0
LMFA01010014
NCGC00091068-02
EDAE4876-C383-4AD4-A419-10C0550931DB
DB08231
prifrac-2942
philacid-1400
CHEMBL111077 ,
BMSE000737
M0476
EN300-78099
NCGC00091068-03
AKOS009156714
HMS3039E15
dtxcid501666
tox21_302781
NCGC00256547-01
cas-544-63-8
dtxsid6021666 ,
NCGC00259401-01
tox21_201852
n-myristic acid
4-02-00-01126 (beilstein handbook reference)
unii-0i3v7s25aw
0i3v7s25aw ,
myristic acid [nf]
FT-0602832
myristic acid (constituent of saw palmetto) [dsc]
myristic acid [ii]
myristic acid [inci]
myristic acid [fhfi]
myristic acid [hsdb]
myristic acid [mart.]
myristic acid [usp-rs]
myristic acid [mi]
myristic acid [fcc]
EPITOPE ID:176772
3USX
3V2N
3W9K
S5617
gtpl2806
SCHEMBL6374
fatty acid 14:0
tridecanecarboxylic acid
hystrene 9514
AC-34674
W-109088
HMS3648O20
mfcd00002744
F8889-5016
myristic acid, >=98.0% (gc)
myristic acid, analytical standard
myristic acid, united states pharmacopeia (usp) reference standard
myristic acid, 95%
myristic acid, puriss.
myristic acid, vetec(tm) reagent grade, 98%
myristic acid, pharmaceutical secondary standard; certified reference material
fa 14:0
1-tridecanecarboxylate
myristic acid pure
myristoate
n-tetradecanoate
myristoic acid
tetradecanoic (myristic) acid
HY-N2041
CS-0018531
tetradecanoic acid; 1-tridecanecarboxylic acid; n-tetradecanoic acid
FT-0770860
DS-3833
Q422658
myristic acid, reagent
magnesiumarsenate
SR-01000854525-3
sr-01000854525
STL185697
CCG-266785
myristicacid-13c14
tetradecanoicacid
BP-27915
myristic acid, ?99%
Z1954802504
myristic-14-13c acid
univol u 3165
myristic acid (constituent of saw palmetto)
myristic acid (ii)
myristic acid (mart.)
naa 142
ch3-(ch2)12-cooh
myristic acid (usp-rs)
tetradecansaeure
acido mynistico
naa 104
is_d27-tetradecanoic acid

Research Excerpts

Overview

Myristic acid is a 14 carbon saturated fatty acid, which is mostly found in milk fat. It has been rarely used as a food additive, limiting the development of natural food preservatives.

ExcerptReferenceRelevance
"Myristic acid appears to be a promising biomarker in sepsis diagnostics, further research by our group into this topic is ongoing."( Kinetics of Myristic Acid Following Accidentally Induced Septic Response.
Dryahina, K; Moravec, M; Müller, M; Nejtek, T; Pehal, F; Průcha, M; Zazula, R, 2019
)
1.61
"Myristic acid is a potential candidate for the prevention and treatment of type 2 diabetes mellitus and its related diseases."( Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes.
Iwata, K; Murakami, C; Sakane, F; Takato, T; Wada, Y, 2017
)
1.48
"Myristic acid is a traditional Chinese herbal medicine, but it has been rarely used as a food additive, limiting the development of natural food preservatives."( Antimicrobial potential of myristic acid against Listeria monocytogenes in milk.
Bu, X; Chen, X; Deng, Y; Guo, N; Ye, H; Zhao, X, 2019
)
1.53
"Myristic acid is a 14 carbon saturated fatty acid, which is mostly found in milk fat. "( [New regulatory and signal functions for myristic acid].
Beauchamp, E; Legrand, P; Rioux, V, 2009
)
2.06

Actions

ExcerptReferenceRelevance
"The myristic acid-associated increase in DES1 activity was not linked to elevated mRNA or protein expression but more likely to its N-terminal myristoylation."( Myristic acid increases dihydroceramide Δ4-desaturase 1 (DES1) activity in cultured rat hepatocytes.
Beauchamp, E; Ezanno, H; Lagadic-Gossmann, D; le Bloc'h, J; Legrand, P; Rioux, V, 2012
)
2.3

Treatment

ExcerptReferenceRelevance
"Treatment with myristic acid, 2-hydroxypalmitic acid, or 2-fluoromyristic acid did not result in the synthesis of nonmyristoylated p56lck."( Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lck.
Ashendel, CL; Cassady, JM; Geahlen, RL; Harrison, ML; Nadler, MJ, 1993
)
0.9

Toxicity

ExcerptReferenceRelevance
" The Panel determined that myristic acid and its salts and esters are safe as cosmetic ingredients in the current practices of use and concentration."( Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics.
Alan Andersen, F; Becker, LC; Belsito, DV; Bergfeld, WF; Hill, RA; Klaassen, CD; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW, 2010
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
", increasing maximum uptake (Cmax), extending serum half-life (t½), and reducing plasma clearance (CL)."( Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related synthetic peptide amide, significantly improves its pharmacokinetic profile and efficacy.
Anderson, BM; Grasso, P; Novakovic, ZM, 2014
)
1.85

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this work, stable isotope labeling in combination with liquid chromatography-tandem mass spectrometry was used for untargeted profiling and relative quantification of carboxyl-containing metabolites in plasma of smokers and non-smokers."( Profiling of carboxyl-containing metabolites in smokers and non-smokers by stable isotope labeling combined with LC-MS/MS.
Chen, H; Chen, J; Fu, Y; He, Y; Hou, H; Hu, Q; Luo, Y, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
"Hypercholesterolemia-induced vascular disease and atherosclerosis are characterized by a decrease in the bioavailability of endothelium-derived nitric oxide."( Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
Blair, A; Conrad, PA; Shaul, PW; Smart, EJ; Yuhanna, IS, 1999
)
0.3
" In this article we compare the two main methods of dissolving FAs for work in vitro, (i) dissolution in dimethylsulfoxide (DMSO) and (ii) conjugation with bovine serum albumin (BSA), and describe the effects of the solvent on cytotoxicity (determination of viability) and bioavailability (as shown by the impact on the gene expression of TNF-alpha)."( Effect of solvent on cytotoxicity and bioavailability of fatty acids.
Hosek, J; Kollar, P; Zavalova, V, 2010
)
0.36
" Pelargonic, lauric, myristic, palmitic, margaric, stearic, and oleic acids were suspended in water dissolved in dimethyl sulfoxide (DMSO) or emulsified in water and quillaja saponin to assess how bioavailability impacted Salmonella growth."( Susceptibility of Salmonella enterica Isolates from Tomato Farm Environments to Fatty Acids Naturally Found on Tomato Fruit.
Dev Kumar, G; Micallef, SA, 2017
)
0.46
" Importantly, myristoylation converts c(MyD 4-4) to an orally bioavailable inhibitor of MyD88."( Myristoylation Confers Oral Bioavailability and Improves the Bioactivity of c(MyD 4-4), a Cyclic Peptide Inhibitor of MyD88.
Dishon, S; Gilon, C; Hoffman, A; Nussbaum, G; Schumacher-Klinger, A, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Membrane-associated wild-type and C3S G(o)1 alpha appeared to interact with guanine nucleotides with similar affinity, as no alteration in the dose-response curves for guanine-nucleotide-induced maintenance of a stable 37 kDa tryptic fragment was noted for the two forms of G(o)1 alpha."( The palmitoylation status of the G-protein G(o)1 alpha regulates its activity of interaction with the plasma membrane.
Grassie, MA; Guzzi, F; Magee, AI; McCallum, JF; Milligan, G; Parenti, M, 1994
)
0.29
" A requirement for PKC betaII for phagocytosis was demonstrated collectively by phorbol 12-myristate 13-acetate-induced depletion of PKC betaII, by dose-response to PKC inhibitor Ro-32-0432, and by use of PKC betaII myristoylated peptide as a blocker."( Activation of protein kinase C beta II by the stereo-specific phosphatidylserine receptor is required for phagocytosis of apoptotic thymocytes by resident murine tissue macrophages.
Curtis, JL; Hu, B; Polak, T; Punturieri, A; Sonstein, J; Todt, JC, 2002
)
0.31
" Dose-response tests with certain of the fatty acids were consistent with the above interpretations and further indicated that the gland had a high capacity for rapidly activating and incorporating excess fatty acids into the glandular lipids."( The effects of topical application of various fatty acids on pheromone and glandular lipid biosynthesis in the moth Heliothis virescens.
Foster, SP, 2004
)
0.32
"The present study demonstrates that octacosanoic acid is formed after incubation of fibroblast cultures with (3)H-octacosanol and after oral dosing with policosanol to rats."( In vitro and in vivo study of octacosanol metabolism.
Fernández, I; González, L; González, RM; Marrero, D; Más, R; Menéndez, R,
)
0.13
" A dose-response accumulation of tissue C16:1 n-7 as a function of dietary C14:0 was also shown."( Dietary myristic acid at physiologically relevant levels increases the tissue content of C20:5 n-3 and C20:3 n-6 in the rat.
Bouriel, M; Catheline, D; Legrand, P; Rioux, V,
)
0.57
" In the main study, 6 lactating dairy cows were dosed intraruminally with 240 g/(cow · d) of stearic (SA, control), lauric (LA), or myristic (MA) acid in a replicated 3 × 3 Latin square design trial."( Rumen bacterial, archaeal, and fungal diversity of dairy cows in response to ingestion of lauric or myristic acid.
Callaway, TR; Dowd, SE; Hristov, AN; Lee, C, 2012
)
0.6
" Pentadecanoic acid induced significant oviposition stimulation, especially when dosed at 10 ppm."( Behavioural and antennal responses of Aedes aegypti (l.) (Diptera: Culicidae) gravid females to chemical cues from conspecific larvae.
Boullis, A; Delannay, C; Héry, L; Mulatier, M; Vega-Rúa, A; Verheggen, F, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (18 Product(s))

Product Categories

Product CategoryProducts
Other1
Aliments et boissons à base de végétaux, Boissons, Aliments d'origine végétale, Substituts de produits laitiers, Substituts du lait, Fruits à coques et dérivés, Boissons à base de végétaux, Boissons végétales, Boissons végétales de fruits à coque, Laits d1
Beauty & Personal Care15
Baby & Kids Products1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
CeraVe Hydrating Mineral Sunscreen Body SPF 50 -- 5 fl ozCeraVeBeauty & Personal Carecaprylyl glycol, citric acid, carbomer, ceramide NP, cetearyl alcohol, chlorphenesin, citric acid, tocopherol, tocopherol, glyceryl stearate, glycerin, dimethicone, myristic acid, triethoxycaprylylsilane, palmitic acid, palmitic acid, phenoxyethanol, phytosphingosine, propanediol, sodium citrate, stearic acid2024-11-29 10:47:42
CeraVe Hydrating Mineral Sunscreen Lotion for Face SPF 30 -- 2.5 fl ozCeraVeBeauty & Personal Carecaprylyl glycol, citric acid, carbomer, ceramide NP, cetearyl alcohol, chlorphenesin, citric acid, panthenol, glyceryl stearate, glycerin, dimethicone, myristic acid, niacinamide, triethoxycaprylylsilane, palmitic acid, palmitic acid, phenoxyethanol, phytosphingosine, propanediol, sodium citrate, stearic acid2024-11-29 10:47:42
CeraVe Itch Relief Moisturizing Lotion for Dry and Itchy Skin -- 8 fl ozCeraVeBeauty & Personal Careallantoin, carbomer, ceramide NP, cetearyl alcohol, cetyl alcohol, disodium EDTA, glyceryl stearate, glycerin, dimethicone, isopropyl myristate, myristic acid, niacinamide, palmitic acid, palmitic acid, phenoxyethanol, phytosphingosine, potassium phosphate, pramoxine hcl, sodium hydroxide, stearic acid2024-11-29 10:47:42
Daeng Gi Meo Ri Medicinal Herb Hair Color - Black -- 1 KitDaeng Gi Meo RiBeauty & Personal Carebutylene glycol, P-aminophenol, PCA, ceteth-20, cetyl alcohol, citronellol, dioleyl phosphate, behenyl alcohol, lauryl alcohol, disodium EDTA, ethanolamine, geraniol, hexyl cinnamal, hydroxycitronellal, butylphenyl methylpropional, limon- ene, linalool, myristic acid, myristyl alcohol, oleyl alcohol, palmitic acid, palmitic acid, phenacetin, resorcinol, sodium benzoate, stearic acid, stearyl alcohol, stearyl stearate, threonine2024-11-29 10:47:42
Daeng Gi Meo Ri Medicinal Herb Hair Color - Natural Brown -- 1 KitDaeng Gi Meo RiBeauty & Personal Carebutylene glycol, P-aminophenol, PCA, ceteth-20, cetyl alcohol, citronellol, dioleyl phosphate, behenyl alcohol, lauryl alcohol, disodium EDTA, ethanolamine, geraniol, hexyl cinnamal, hydroxycitronellal, butylphenyl methylpropional, limon- ene, linalool, myristic acid, myristyl alcohol, oleyl alcohol, palmitic acid, palmitic acid, phenacetin, resorcinol, sodium benzoate, stearic acid, stearyl alcohol, stearyl stearate, threonine2024-11-29 10:47:42
Derma E Vitamin C Gentle Daily Cleansing Paste -- 4 ozDerma EBeauty & Personal Carebehenic acid, vitamin E, panthenol, vitamin E, glycerin, hydroxyethylcellulose, kaolin, lauric acid, myristic acid, palmitic acid, palmitic acid, potassium hydroxide, stearic acid, titanium dioxide2024-11-29 10:47:42
Duke Cannon Superior Grade Shaving Cream -- 6 ozDuke CannonBeauty & Personal CareCaprylyl Glycol, Citric Acid, Allantoin, Cetyl Alcohol, Citric Acid, Ethylhexylglycerin, Glycerin, Hexylene Glycol, Myristic Acid, Phenoxyethanol, Xylitol2024-11-29 10:47:42
Kiss My Face Moisture Shave - Cedarwood + Bergamot -- 11 fl ozKiss My FaceBeauty & Personal Careorange, allantoin, goldenseal, glycerin, hydroxyethylcellulose, myristic acid, phenoxyethanol, potassium hydroxide, stearic acid2024-11-29 10:47:42
Kiss My Face Moisture Shave Cool Mint -- 11 fl ozKiss My FaceBeauty & Personal Careorange, allantoin, goldenseal, glycerin, hydroxyethylcellulose, myristic acid, phenoxyethanol, potassium hydroxide, stearic acid2024-11-29 10:47:42
Kiss My Face Moisture Shave Fragrance Free -- 11 fl ozKiss My FaceBeauty & Personal Careorange, allantoin, goldenseal, glycerin, hydroxyethylcellulose, myristic acid, phenoxyethanol, potassium hydroxide, stearic acid2024-11-29 10:47:42
Kiss My Face Moisture Shave Lavender Shea -- 11 fl ozKiss My FaceBeauty & Personal Careorange, allantoin, goldenseal, glycerin, hydroxyethylcellulose, myristic acid, phenoxyethanol, potassium hydroxide, stearic acid2024-11-29 10:47:42
Mad Hippie Microdermabrasion Facial -- 2.1 ozMad HippieBeauty & Personal Carecaprylyl glycol, orange, cetyl alcohol, ethylhexyl glycerin, glycerin, glycolic acid, lactic acid, mandelic acid, probiotic, myristic acid, phenethyl alcohol, squalane, stearic acid2024-11-29 10:47:42
Peet Bros Shea Butter Moisturizing Hand & Body Lotion Argan & Sandalwood -- 10 ozPeet BrosBeauty & Personal Carebenzyl alcohol, glycerin, glycerol monolaurate, myristic acid2024-11-29 10:47:42
SheaMoisture African Black Soap Facial Wash & Scrub to Clarify Blemish-Prone Skin -- 4 ozSheaMoistureBeauty & Personal Carecaprylyl glycol, bisabolol, cetyl alcohol, palm, decyl glucoside, panthenol, glycerin, glyceryl laurate, myristic acid, myristyl alcohol, potassium hydroxide, salicylic acid, sodium benzoate, stearic acid2024-11-29 10:47:42
SheaMoisture African Black Soap with Shea Butter Clarifying Facial Wash & Scrub for Problem Skin -- 1.5 ozSheaMoistureBeauty & Personal Careorange, chamomile, bisabolol, decyl glucoside, panthenol, glycerine, myristic acid, vitamin B-5, salicylic acid, stearic acid2024-11-29 10:47:42
The Honest Company Eczema Soothing Therapy Body Wash Baby Safe -- 8 fl ozThe Honest CompanyBaby & Kids Productscitric acid, allantoin, cetyl alcohol, citric acid, tocopherol, panthenol, tocopherol, glycerin, malic acid, myristic acid, trisodium ethylenediamine disuccinate, oat, palmitic acid, palmitic acid, pantolactone, propanediol, stearic acid2024-11-29 10:47:42

Roles (4)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
EC 3.1.1.1 (carboxylesterase) inhibitorAny EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that inhibits the action of carboxylesterase (EC 3.1.1.1 ).
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
long-chain fatty acidA fatty acid with a chain length ranging from C13 to C22.
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
Fatty Acid Biosynthesis233
fatty acid oxidation (myristate)614
Omega-9 fatty acid synthesis226
Fatty Acid Oxidation (Myristate)214
Mitochondrial beta-oxidation064
AtMetExpress overview0109
Omega-9 and other unsaturated fatty acids biosynthesis pathway017

Protein Targets (42)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency6.30960.004023.8416100.0000AID485290
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
LuciferasePhotinus pyralis (common eastern firefly)Potency52.83230.007215.758889.3584AID1224835; AID588342
acid sphingomyelinaseHomo sapiens (human)Potency223.872014.125424.061339.8107AID504937
glp-1 receptor, partialHomo sapiens (human)Potency14.12540.01846.806014.1254AID624417
USP1 protein, partialHomo sapiens (human)Potency63.09570.031637.5844354.8130AID743255
TDP1 proteinHomo sapiens (human)Potency5.80480.000811.382244.6684AID686978
GLI family zinc finger 3Homo sapiens (human)Potency23.65590.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency61.50150.000221.22318,912.5098AID743035
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency60.94410.000657.913322,387.1992AID1259377
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.94770.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency15.30850.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency44.80870.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency3.84530.001530.607315,848.9004AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency0.00320.375827.485161.6524AID588527
pregnane X nuclear receptorHomo sapiens (human)Potency27.30600.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.65840.000229.305416,493.5996AID743069; AID743075
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency53.41090.001024.504861.6448AID743212; AID743227
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency12.30130.001019.414170.9645AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency19.95260.023723.228263.5986AID588543
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency48.68810.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency48.97220.042027.378961.6448AID743210
flap endonuclease 1Homo sapiens (human)Potency100.00000.133725.412989.1251AID588795
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency29.93490.168316.404067.0158AID720504
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency12.58930.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency2.31090.004611.374133.4983AID624297
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency15.84890.251215.843239.8107AID504327
lethal factor (plasmid)Bacillus anthracis str. A2012Potency31.62280.020010.786931.6228AID912
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency31.62280.316212.765731.6228AID881
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency56.23416.309660.2008112.2020AID720707
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency31.62280.00638.235039.8107AID881
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)Potency33.52780.015823.527344.6684AID651778
TAR DNA-binding protein 43Homo sapiens (human)Potency0.70791.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Toll-like receptor 2Homo sapiens (human)IC50 (µMol)5.00005.00005.00005.0000AID261940
Prostaglandin G/H synthase 1 Bos taurus (cattle)IC50 (µMol)500.00000.00051.41288.2000AID360928
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)500.00000.00101.453910.0000AID360927
Dynamin-1Homo sapiens (human)IC50 (µMol)100.00003.15004.17335.0000AID63727
G-protein coupled receptor 84Homo sapiens (human)Ki2.64000.02361.29013.3100AID1546369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)EC50 (µMol)13.00000.00061.607410.0000AID1901640
G-protein coupled receptor 84Homo sapiens (human)EC50 (µMol)10.93670.08903.868710.0000AID1546364; AID1546366; AID1707045
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (197)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of interleukin-8 productionToll-like receptor 2Homo sapiens (human)
detection of triacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
detection of diacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityToll-like receptor 2Homo sapiens (human)
cellular response to lipoteichoic acidToll-like receptor 2Homo sapiens (human)
cellular response to diacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
cellular response to triacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
response to hypoxiaToll-like receptor 2Homo sapiens (human)
microglial cell activationToll-like receptor 2Homo sapiens (human)
toll-like receptor signaling pathwayToll-like receptor 2Homo sapiens (human)
leukotriene metabolic processToll-like receptor 2Homo sapiens (human)
apoptotic processToll-like receptor 2Homo sapiens (human)
immune responseToll-like receptor 2Homo sapiens (human)
signal transductionToll-like receptor 2Homo sapiens (human)
I-kappaB phosphorylationToll-like receptor 2Homo sapiens (human)
learningToll-like receptor 2Homo sapiens (human)
negative regulation of cell population proliferationToll-like receptor 2Homo sapiens (human)
response to toxic substanceToll-like receptor 2Homo sapiens (human)
positive regulation of gene expressionToll-like receptor 2Homo sapiens (human)
microglia developmentToll-like receptor 2Homo sapiens (human)
positive regulation of Wnt signaling pathwayToll-like receptor 2Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayToll-like receptor 2Homo sapiens (human)
central nervous system myelin formationToll-like receptor 2Homo sapiens (human)
response to progesteroneToll-like receptor 2Homo sapiens (human)
positive regulation of chemokine productionToll-like receptor 2Homo sapiens (human)
positive regulation of interferon-beta productionToll-like receptor 2Homo sapiens (human)
positive regulation of interleukin-10 productionToll-like receptor 2Homo sapiens (human)
positive regulation of interleukin-12 productionToll-like receptor 2Homo sapiens (human)
positive regulation of interleukin-18 productionToll-like receptor 2Homo sapiens (human)
positive regulation of interleukin-6 productionToll-like receptor 2Homo sapiens (human)
positive regulation of interleukin-8 productionToll-like receptor 2Homo sapiens (human)
positive regulation of tumor necrosis factor productionToll-like receptor 2Homo sapiens (human)
response to insulinToll-like receptor 2Homo sapiens (human)
toll-like receptor 2 signaling pathwayToll-like receptor 2Homo sapiens (human)
toll-like receptor TLR6:TLR2 signaling pathwayToll-like receptor 2Homo sapiens (human)
innate immune responseToll-like receptor 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIToll-like receptor 2Homo sapiens (human)
nitric oxide metabolic processToll-like receptor 2Homo sapiens (human)
positive regulation of oligodendrocyte differentiationToll-like receptor 2Homo sapiens (human)
positive regulation of inflammatory responseToll-like receptor 2Homo sapiens (human)
negative regulation of phagocytosisToll-like receptor 2Homo sapiens (human)
defense response to Gram-positive bacteriumToll-like receptor 2Homo sapiens (human)
positive regulation of NF-kappaB transcription factor activityToll-like receptor 2Homo sapiens (human)
defense response to virusToll-like receptor 2Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic processToll-like receptor 2Homo sapiens (human)
negative regulation of synapse assemblyToll-like receptor 2Homo sapiens (human)
response to fatty acidToll-like receptor 2Homo sapiens (human)
cellular response to bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
cellular response to lipoteichoic acidToll-like receptor 2Homo sapiens (human)
cellular response to type II interferonToll-like receptor 2Homo sapiens (human)
cellular response to diacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
cellular response to triacyl bacterial lipopeptideToll-like receptor 2Homo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionToll-like receptor 2Homo sapiens (human)
positive regulation of cellular response to macrophage colony-stimulating factor stimulusToll-like receptor 2Homo sapiens (human)
positive regulation of matrix metallopeptidase secretionToll-like receptor 2Homo sapiens (human)
inflammatory responseToll-like receptor 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1 Bos taurus (cattle)
cellular oxidant detoxificationProstaglandin G/H synthase 1 Bos taurus (cattle)
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
generation of precursor metabolites and energyPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid beta-oxidationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
embryo implantationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cholesterol metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell population proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
axon ensheathmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid catabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of skeletal muscle satellite cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell-substrate adhesionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to nutrient levelsPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of skeletal muscle tissue regenerationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of myoblast differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
decidualizationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of epithelial cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte migrationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
adipose tissue developmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
energy homeostasisPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose transmembrane transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of myoblast proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
endocytosisDynamin-1Homo sapiens (human)
receptor-mediated endocytosisDynamin-1Homo sapiens (human)
endosome organizationDynamin-1Homo sapiens (human)
modulation of chemical synaptic transmissionDynamin-1Homo sapiens (human)
protein homooligomerizationDynamin-1Homo sapiens (human)
protein homotetramerizationDynamin-1Homo sapiens (human)
regulation of vesicle sizeDynamin-1Homo sapiens (human)
clathrin coat assembly involved in endocytosisDynamin-1Homo sapiens (human)
vesicle scissionDynamin-1Homo sapiens (human)
receptor internalizationDynamin-1Homo sapiens (human)
synaptic vesicle budding from presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
biological_processG-protein coupled receptor 84Homo sapiens (human)
neuropeptide signaling pathwayG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (61)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipopolysaccharide bindingToll-like receptor 2Homo sapiens (human)
amyloid-beta bindingToll-like receptor 2Homo sapiens (human)
lipopolysaccharide immune receptor activityToll-like receptor 2Homo sapiens (human)
transmembrane signaling receptor activityToll-like receptor 2Homo sapiens (human)
protein bindingToll-like receptor 2Homo sapiens (human)
Toll-like receptor bindingToll-like receptor 2Homo sapiens (human)
pattern recognition receptor activityToll-like receptor 2Homo sapiens (human)
triacyl lipopeptide bindingToll-like receptor 2Homo sapiens (human)
identical protein bindingToll-like receptor 2Homo sapiens (human)
peptidoglycan bindingToll-like receptor 2Homo sapiens (human)
protein-containing complex bindingToll-like receptor 2Homo sapiens (human)
NAD+ nucleotidase, cyclic ADP-ribose generatingToll-like receptor 2Homo sapiens (human)
signaling receptor activityToll-like receptor 2Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1 Bos taurus (cattle)
heme bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
metal ion bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
linoleic acid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
sequence-specific double-stranded DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA bindingDynamin-1Homo sapiens (human)
GTPase activityDynamin-1Homo sapiens (human)
protein bindingDynamin-1Homo sapiens (human)
GTP bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingDynamin-1Homo sapiens (human)
GDP bindingDynamin-1Homo sapiens (human)
protein kinase bindingDynamin-1Homo sapiens (human)
identical protein bindingDynamin-1Homo sapiens (human)
protein homodimerization activityDynamin-1Homo sapiens (human)
microtubule bindingDynamin-1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
urotensin II receptor activityG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (46)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoplasmToll-like receptor 2Homo sapiens (human)
Golgi apparatusToll-like receptor 2Homo sapiens (human)
plasma membraneToll-like receptor 2Homo sapiens (human)
cell surfaceToll-like receptor 2Homo sapiens (human)
secretory granule membraneToll-like receptor 2Homo sapiens (human)
phagocytic vesicle membraneToll-like receptor 2Homo sapiens (human)
Toll-like receptor 1-Toll-like receptor 2 protein complexToll-like receptor 2Homo sapiens (human)
Toll-like receptor 2-Toll-like receptor 6 protein complexToll-like receptor 2Homo sapiens (human)
cell projectionToll-like receptor 2Homo sapiens (human)
receptor complexToll-like receptor 2Homo sapiens (human)
cell bodyToll-like receptor 2Homo sapiens (human)
membrane raftToll-like receptor 2Homo sapiens (human)
plasma membraneToll-like receptor 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1 Bos taurus (cattle)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
photoreceptor inner segmentDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
clathrin-coated pitDynamin-1Homo sapiens (human)
endocytic vesicleDynamin-1Homo sapiens (human)
chromaffin granuleDynamin-1Homo sapiens (human)
cell projectionDynamin-1Homo sapiens (human)
extracellular exosomeDynamin-1Homo sapiens (human)
photoreceptor ribbon synapseDynamin-1Homo sapiens (human)
presynapseDynamin-1Homo sapiens (human)
presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
glutamatergic synapseDynamin-1Homo sapiens (human)
membrane coatDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
synapseDynamin-1Homo sapiens (human)
microtubuleDynamin-1Homo sapiens (human)
cytoplasmDynamin-1Homo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
specific granule membraneG-protein coupled receptor 84Homo sapiens (human)
tertiary granule membraneG-protein coupled receptor 84Homo sapiens (human)
receptor complexG-protein coupled receptor 84Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (108)

Assay IDTitleYearJournalArticle
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1707045Agonist activity at human GPR84 expressed in CHO cell membranes assessed as induction of [35S]GTPgammaS incorporation incubated for 1 hr by liquid scintillation counting method2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
AID1546366Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 5 mins followed by forskolin stimulation and measured after 15 m2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID1811314Selectivity index, ratio of CC50 for human Huh-7 cells to IC50 for Antiviral activity against Ebola virus trVLP infected in human Huh-7 cells2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
AID1811322Antiviral activity against Ebola virus constitutively expressed firefly infected in human Huh-7 cells expressing pretreated for 1 hrs followed by viral infection and measured after 24 hrs by dual luciferase reporter assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
AID1083131Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083135Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID40631Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined at 2 x 10E-4 M1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1546370Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as beta-arrestin 2 recruitment measured after 90 mins by beta-galactosidase based PathHunter assay relative to embelin2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1082355Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082348Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082345Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID597407Antibacterial activity against Staphylococcus aureus by broth microdilution method2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
AID597408Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution method2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Comparing micellar, hemolytic, and antibacterial properties of di- and tricarboxyl dendritic amphiphiles.
AID1083122Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 24 hr Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1901643Agonist activity at human PPARalpha expressed in HEK293 cells assessed as maximal activity by luciferase/beta-galactosidase reporter gene assay relative to GW76472022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1082356Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1901633Agonist activity at human PPARalpha transfected in HEK293 cells assessed as relative luciferase unit at 50 uM measured after 16 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1082359Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083137Nematicidal activity against Meloidogyne incognita (root-knot nematode) root-knot nematodes assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083130Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082344Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID264976Antibacterial activity against Staphylococcus aureus2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
AID1083124Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 24 hr (Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1901640Agonist activity at human PPARalpha expressed in HEK293 cells by luciferase/beta-galactosidase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1546365Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as inhibition of forskolin-stimulated [3H]cAMP accumulation preincubated for 5 mins followed by forskolin stimulation and measured after 15 m2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1082341Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083129Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 14 (SDW control = 35.77 +/- 4.48%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082357Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083133Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082332Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082358Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082329Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082324Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082350Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082352Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082360Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082334Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082333Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082323Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1811321Antiviral activity against Ebola virus trVLP infected in human Huh-7 cells pretreated for 1 hrs followed by viral infection and measured after 24 hrs by dual luciferase reporter assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
AID376615Inhibition of aromatase in human placental microsomes at 20 ug/ml by radiometric method relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
AID1082338Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083126Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082342Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID63727Concentration required against dynamin-1 GTPase activity of sheep brain.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.
AID261940Inhibition of TLR2 agonist Pam3Cys-Ser-(Lys)4-OH-mediated IL8 secretion in THP1 cells2006Journal of medicinal chemistry, Mar-09, Volume: 49, Issue:5
Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
AID1082326Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082347Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1546364Agonist activity at recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 assessed as beta-arrestin 2 recruitment measured after 90 mins by beta-galactosidase based PathHunter assay2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1082343Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID264978Antibacterial activity against Escherichia coli2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
AID1901645Agonist activity at human PPARdelta expressed in HEK293 cells assessed as maximal activity by luciferase/beta-galactosidase reporter gene assay relative to GW07422022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1082351Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1417297Inhibition of equine serum BuChE at 10 M using butyrylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID1083125Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 100 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082339Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082337Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID360928Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID1083132Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 2000 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083127Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID264977Antibacterial activity against Micrococcus luteus2006Bioorganic & medicinal chemistry letters, Jun-01, Volume: 16, Issue:11
Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
AID1082336Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1901642Agonist activity at human PPARdelta expressed in HEK293 cells by luciferase/beta-galactosidase reporter gene assay2022Journal of medicinal chemistry, 02-10, Volume: 65, Issue:3
Phenolic Lipids Derived from Cashew Nut Shell Liquid to Treat Metabolic Diseases.
AID1082330Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 48 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082346Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083120Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 24 hr Rvb = 1.47 to 2.51%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083136Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 1000 umol/L on day 3 (SDW control = 0.57 +/- 0.37%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083121Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 2000 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1083128Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 21 (SDW control = 44.87 +/- 3.93%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1811315Antiviral activity against SARS Cov-2 USA/WA1/2020 infected in Vero E6 cells assessed as reduction in virus-induced cytopathic effect preincubated for 1 hr followed by viral infection and measured after 48 hrs post infection2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
AID1546369Displacement of [3H]PSB-1584 from recombinant human GPR84 expressed in CHO cell membranes co-expressing beta-arrestin2 measured after 6 hrs by scintillation counting method2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1082331Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082328Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082325Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083134Nematicidal activity against Meloidogyne incognita (root-knot nematode) assessed as cumulative percentage of egg hatching at 25 degC at 100 umol/L on day 7 (SDW control = 12.63 +/- 3.84%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1082327Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1083123Nematicidal activity against second-stage juvenile of Meloidogyne incognita (root-knot nematode) assessed as mortality at 25 degC at 1000 umol/L after 12 hr (Rvb = 1.79 to 3.30%)2012Journal of agricultural and food chemistry, Nov-21, Volume: 60, Issue:46
Potential antagonistic effects of nine natural fatty acids against Meloidogyne incognita.
AID1417295Inhibition of electric eel AChE at 10 M using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition and measured at 1 min intervals for 30 mins by Ellman's method2018Bioorganic & medicinal chemistry letters, 11-01, Volume: 28, Issue:20
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.
AID1811320Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability measured after 24 hrs by CellTiter-Glo analysis2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
AID1082340Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1082335Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID360927Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID1082349Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy2011Journal of agricultural and food chemistry, Sep-14, Volume: 59, Issue:17
Isolation of nematicidal compounds from Tagetes patula L. yellow flowers: structure-activity relationship studies against cyst nematode Heterodera zeae infective stage larvae.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2003Nature, Mar-13, Volume: 422, Issue:6928
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2003Biochemical and biophysical research communications, Feb-07, Volume: 301, Issue:2
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2003The Journal of biological chemistry, Mar-28, Volume: 278, Issue:13
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.
AID1345188Human FFA4 receptor (Free fatty acid receptors)2012Molecular pharmacology, May, Volume: 81, Issue:5
Differential signaling by splice variants of the human free fatty acid receptor GPR120.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2012PloS one, , Volume: 7, Issue:11
The pentameric channel of COMPcc in complex with different fatty acids.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Journal of bacteriology, Sep, Volume: 195, Issue:17
A thermoacidophile-specific protein family, DUF3211, functions as a fatty acid carrier with novel binding mode.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Archives of biochemistry and biophysics, Jan-01, Volume: 529, Issue:1
Structural basis of the binding of fatty acids to peptidoglycan recognition protein, PGRP-S through second binding site.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,699)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990171 (10.06)18.7374
1990's610 (35.90)18.2507
2000's459 (27.02)29.6817
2010's368 (21.66)24.3611
2020's91 (5.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 71.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index71.15 (24.57)
Research Supply Index7.47 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index125.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (71.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials24 (1.39%)5.53%
Reviews65 (3.76%)6.00%
Case Studies6 (0.35%)4.05%
Observational1 (0.06%)0.25%
Other1,631 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]